ArticleInternal medicine (Tokyo, Japan)2023
COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung Disease.
Tomoya Tateishi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.